Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg

Author： Brunton Stephen   Kuritzky Louis  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.1, 2005-01, pp. : 71-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

By Speakman Mark   Khullar Vik   Mundy Anthony   Odeyemi Isaac   Bolodeoku John  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2173-2179

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression

By Cowen Philip J.   Ogilvie Alan D.   Gama Joubert  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite

Combination of solifenacin and mirabegron for overactive bladder management

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 498-499

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

By  

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley   Cardozo Linda  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite